BioNTech SE (BNTX) Inventory Average (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Inventory Average data on file, last reported at $196.4 million in Q4 2025.

• In Q4 2025, Inventory Average fell 38.21% year-over-year to $196.4 million; the TTM figure through Dec 2025 stood at $196.4 million (down 38.21% YoY), while the FY2025 annual figure was $213.9 million, down 37.78% from the prior year.
• Inventory Average eased to $196.4 million in Q4 2025, from $262.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $10.5 billion in Q3 2021 and bottomed at $196.4 million in Q4 2025.
• A 5-year average of $2.0 billion and a median of $435.3 million in 2023 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2021 — Inventory Average jumped 13231.9% — and 2022, when it plunged 94.3%.
• Year by year, Inventory Average stood at $6.5 billion in 2021, then plunged by 94.3% to $372.9 million in 2022, then increased by 12.29% to $418.7 million in 2023, then dropped by 24.1% to $317.8 million in 2024, then sank by 38.21% to $196.4 million in 2025.
• The last three Inventory Average figures came in at $196.4 million (Q4 2025), $262.5 million (Q3 2025), and $264.4 million (Q2 2025), per Business Quant data.

Peer Comparison